EUVIMEDEUVIMED entdecken
Open Access

The SGK3/GSK3β/β-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy

Tingting Kang, Yuanfang Wang, Yaxin Jiang, Shunjie Chen, Na Lin, Minyan Guo, Haotu Zhu, Di Tang, Xiaofan Ding, Mian He

International Journal of Biological Sciences · 2025

DOI: 10.7150/ijbs.104850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Tingting Kang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Glycogen Synthase Kinase 3 beta, beta Catenin. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDrug Resistance, NeoplasmGlycogen Synthase Kinase 3 betabeta CateninProtein Serine-Threonine KinasesThiazolesHumansFemaleCell Line, TumorSignal TransductionNeoplastic Stem CellsApoptosisAnimalsMiceSerum-Glucocorticoid Regulated Kinases

Stichwörter der Autor:innen

AlpelisibSGK3drug resistancestem cellβ-catenin

Substanzen

Glycogen Synthase Kinase 3 betabeta CateninProtein Serine-Threonine KinasesThiazolesSGK3 protein, humanSerum-Glucocorticoid Regulated KinasesAlpelisib

Autor:innen und Institutionen

  • Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
  • Department of General Surgery, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
  • Faculty of Health Sciences, University of Macau, Macau SAR, China.
  • Department of Oncology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.
  • MOE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, China.
  • Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Zitieren

APA

Kang, T., Wang, Y., Jiang, Y., Chen, S., Lin, N., Guo, M., Zhu, H., Tang, D., Ding, X., & He, M. (2025). The SGK3/GSK3β/β-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.104850

Vancouver

Kang T, Wang Y, Jiang Y, Chen S, Lin N, Guo M, et al. The SGK3/GSK3β/β-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.104850

BibTeX
@article{Kang2025,
  author = {Kang, Tingting and Wang, Yuanfang and Jiang, Yaxin and Chen, Shunjie and Lin, Na and Guo, Minyan and Zhu, Haotu and Tang, Di and Ding, Xiaofan and He, Mian},
  title = {The SGK3/GSK3β/β-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  doi = {10.7150/ijbs.104850}
}
Kostenlos starten →